Skip to content

Drug interactions

Elagolix + Netupitant-palonosetron

Severity: Minor

Elagolix and Netupitant-palonosetron: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Elagolix is a weak-to-moderate CYP3A4 inducer and may lower netupitant concentrations. The reduction may be of limited clinical significance for single-dose antiemetic use.

What this interaction means in plain words

Elagolix and Netupitant-palonosetron have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Elagolix belongs to Musculoskeletal; Netupitant-palonosetron belongs to Gastrointestinal Tract.

Evidence level: Low

Why it happens

Elagolix induces CYP3A4, increasing netupitant metabolism.

What to do

Monitor for breakthrough nausea and vomiting. No routine dose adjustment is needed.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Elagolix and Netupitant-palonosetron, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Elagolix with Netupitant-palonosetron?

MediHelp rates the interaction as minor. Elagolix and Netupitant-palonosetron have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Elagolix is a weak-to-moderate CYP3A4 inducer and may lower netupitant concentrations. The reduction may be of limited clinical significance for single-dose antiemetic use.

How serious is the interaction between Elagolix and Netupitant-palonosetron?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor for breakthrough nausea and vomiting. No routine dose adjustment is needed.

What other medicines interact with Netupitant-palonosetron?

MediHelp also lists interactions of Netupitant-palonosetron with, for example, Apomorphine, Flibanserin, Apalutamide. The full list is on the Netupitant-palonosetron page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in